Updated: 5/2/2013
The ISBT 128 labeling standard has received endorsements and support from various international organizations. In this section you will have an opportunity read the positive feedback ICCBBA has received.
View the endorsements in the following areas:
Then World Health Organization (WHO) has released a bulletin acknowledging that,
"The development of an international coding system for Medical Product of Human Origin (MPHO) requires either creating a new system or ensuring a role for the ICCBBA as provider of the global service for nomenclature and coding. Attaining the WHA63.22 objective of globally consistent coding systems will involve the gradual adoption of ISBT 128 by organizations as an element of their development programmes."
View the full bulletin here:
http://www.who.int/bulletin/volumes/91/5/12-116988/en/
03 May 2013
The World Health Organization and ICCBBA held a joint workshop in August 2012 to develop a strategy to achieve the World Health Assembly objective of a globally consistent coding systems for human cells, tissues and organs. See the statement released from the workshop here.
28 September 2012
Statement of the European Blood Alliance position on the labelling, coding and identification of blood, blood components, tissues and cells
At the Board Meeting in Valletta, Malta, the EBA Board has voted to support the universal use of the ISBT 128 for labelling, coding and
identification of blood, blood components, tissues and cells.
EBA Position Paper on Coding and Labeling - PDF Oct 1, 2010
Statement of the International Society of Blood Transfusion position on the labelling, coding and identification of blood, blood components, tissues, cells and organs.
View the paper online: http://www.isbtweb.org/about-isbt/partners/iccbba/
The United Kingdom National Health Service has published two articles regarding ICCBBA and ISBT 128 labeling in their latest online issue of NHS Blood and Transplant Matters. The articles can be found on page 13 and 14.
08 June 2010
The World Marrow Donor Association (WMDA) has posted a position paper discussing how to handle facility confidentiality when labeling Cellular Therapy products from unrelated donors
In this paper the, "WMDA encourages the efforts to adapt ISBT 128 as an effective bar-coded information coding system that supports a globally unique identity,standardized product coding and full traceability of cellular therapy products."
See the position paper here:
WMDA Position Paper - PDF
12 August 2011
The World Network for Blood and Marrow Transplantation” has submitted a letter to the European Commission (EC) supporting ISBT 128 for Cellular Therapy products and recommending that the EC provide a clear indication that the implementation of ISBT 128 for cellular therapy products will be compatible with the European Coding System
See the WBMT letter to the European Commission here: http://www.wbmt.org/
12 August 2011
The Boards of AABB, ASBMT, ASFA, EBMT, FACT, ICCBBA, ISBT, ISCT, JACIE, NMDP and WMDA issued a consensus statement in support of the use of ISBT 128 in the coding of hematopoietic progenitor cell and other therapeutic cell products.
The Boards of the above organizations encourage cell therapy facilities to move forward with the implementation of ISBT 128 coding and labeling.
Joint Statement - PDF
21 March 2011
The Boards of the Association of Eye Banks of Asia, Eye Bank Association of Australia and New Zealand, Eye Bank Association of America, Eye Bank Association of India, European Eye Bank Association, Pan-American Association of Eye Banks, and ICCBBA; confirm their support for the international use of ISBT 128 in the coding of ocular tissue.
The Boards of the above organizations encourage Eye Banks to:
• Adopt this standard terminology for use in communications and in the labeling of ocular tissue grafts;
• Implement ISBT 128 globally unique donation identification for ocular tissue grafts;
• Move towards full implementation of ISBT 128 nomenclature, coding and labeling in accordance with guidance published by the eye bank technical advisory group.
view the joint statement here.
Then World Health Organization (WHO) has released a bulletin acknowledging that,
"The development of an international coding system for Medical Product of Human Origin (MPHO) requires either creating a new system or ensuring a role for the ICCBBA as provider of the global service for nomenclature and coding. Attaining the WHA63.22 objective of globally consistent coding systems will involve the gradual adoption of ISBT 128 by organizations as an element of their development programmes."
View the full bulletin here:
http://www.who.int/bulletin/volumes/91/5/12-116988/en/
03 May 2013
The World Health Organization and ICCBBA held a joint workshop in August 2012 to develop a strategy to achieve the World Health Assembly objective of a globally consistent coding systems for human cells, tissues and organs. See the statement released from the workshop here.
28 September 2012
